Microfluidic manufacturing of Tioconazole loaded keratin nanocarriers: development and optimization by Design of Experiments

• Published in: International journal of pharmaceutics 2023-11, Vol.647, p.123489-123489, Article 123489
• Main Authors: Khorshid, Shiva, Goffi, Rosita, Maurizii, Giorgia, Benedetti, Serena, Sotgiu, Giovanna, Zamboni, Roberto, Buoso, Sara, Galuppi, Roberta, Bordoni, Talita, Tiboni, Mattia, Aluigi, Annalisa, Casettari, Luca
• Format: Article
• Language: English
• Subjects: antifungal therapy; Design of Experiment; Keratin; microfluidics; mycosis; nanomedicine
• ISSN: 0378-5173; 1873-3476
• DOI: 10.1016/j.ijpharm.2023.123489

[Display omitted] •Tioconazole-loaded keratin nanoparticles were prepared by microfluidic approach;•The manufacturing process was optimized using the design of experiments concepts;•The formulation showed a significant inhibitory effect towards Microsporum canis.•The formulations showed acceptable in vitro biocompatibility.•The formulation is a promising drug delivery system for the treatment of mycosis. Fungal infections of the skin, nails, and hair are a common health concern affecting a significant proportion of the population worldwide. The current treatment options include topical and systematic agents which have low permeability and prolonged treatment period, respectively. Consequently, there is a growing need for a permeable, effective, and safe treatment. Keratin nanoparticles are a promising nanoformulation that can improve antifungal agent penetration, providing sustainable targeted drug delivery. In this study, keratin nanoparticles were prepared using a custom-made 3D-printed microfluidic chip and the manufacturing process was optimized using the design of experiments (DoE) approach. The total flow rate (TFR), flow rate ratio (FRR), and keratin concentration were found to be the most influential factors of the size and polydispersity index (PDI) of the nanoparticles. The crosslinking procedure by means of tannic acid as safe and biocompatible compound was also optimized. Keratin nanoparticles loaded with a different amount of tioconazole showed a size lower than 200 nm, a PDI lower than 0.2 and an encapsulation efficiency of 91 ± 1.9 %. Due to their sustained drug release, the formulations showed acceptable in vitro biocompatibility. Furthermore, a significant inhibitory effect compared to the free drug against Microsporum canis.